Recent research has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.
Analytical Chemistry
Jan 19, 2024
0
37
Sentinel lymph node (SLN) is the first lymph node draining from a tumor, and sentinel lymph node biopsy (SLNB) for breast cancer is the standard procedure for clinically node-negative (cN0) early-stage breast cancer. Currently, ...
Bio & Medicine
Nov 16, 2023
0
17
Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated ...
Bio & Medicine
Sep 13, 2022
0
155
Researchers at Michigan State University have shown that locusts can not only "smell" the difference between cancer cells and healthy cells, but they can also distinguish between different cancer cell lines.
Plants & Animals
Aug 5, 2022
0
385
A team of researchers at Osaka University, in collaboration with the University of Bordeaux and the Bergonié Institute in France, has succeeded in terahertz imaging of early-stage breast cancer less than 0.5 mm without staining, ...
Optics & Photonics
Oct 20, 2020
0
10
A new, groundbreaking study by the Hebrew University of Jerusalem (HU) found a way to transform skin cells into the three major stem cell types that comprise early-stage embryos. This work has significant implications for ...
Cell & Microbiology
May 1, 2019
2
865
Chemotherapy isn't supposed to make your hair fall out—it's supposed to kill cancer cells. A new molecular delivery system created at U of T could help ensure that chemotherapy drugs get to their target while minimizing ...
Bio & Medicine
Feb 19, 2016
0
66
